• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-018
Medical Device Problem Code Difficult to Fold, Unfold or Collapse (1254)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/24/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Na.The device is not returning for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event or Problem Description
It was reported that on (b)(6) 2026, a 19mm amplatzer septal occluder was chosen for an atrial septal defect using a 9f amplatzer trevisio intravascular delivery system.During procedure, it was noted that the rims were thin, and balloon sizing showed a maximum measurable diameter of 19¿20 mm.Therefore, a 19mm device was selected initially.During the attempt to implant inside the body, continuous contact with the aorta was observed, and the device was determined to be oversized.Additionally, because the defect morphology was elliptical, it was considered that downsizing the device would not increase the risk of device embolization.There were no bends or kinks been observed in the delivery sheath.The device was therefore changed to a new 18mm amplatzer septal occluder and transesophageal echocardiogram (tee) imaging confirmed that there were no issues following device replacement.The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.The patient was reported stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL #3014918977
edificio #44 calle 0, ave. 2
el coyol alajuela 1897- 4050
CS   1897-4050
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key24912380
Report Number2135147-2026-02489
Device Sequence Number21142674
Product Code MLV
UDI-Device Identifier00811806010151
UDI-Public(01)00811806010151(17)300131(10)10706954
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P000039
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/15/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number9-ASD-018
Device Catalogue Number9-ASD-018
Device Lot Number10706954
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/25/2026
Supplement Date Received by Manufacturer05/09/2026
Initial Report FDA Received Date04/17/2026
Supplement Report FDA Received Date05/15/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/03/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
9F AMPLATZER TREVISIO INTRAVASCULAR DELIVERY SYSTE.
Patient SexUnknown
-
-